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A B S T R A C T
Clostridium botulinum produces the botulinum neurotoxin (BoNT). Previously, we provided evidence for the
“building-block” model of botulinum toxin complex (TC). In this model, a single BoNT is associated with a
single nontoxic nonhemagglutinin (NTNHA), yielding M-TC; three HA-70 molecules are attached and form M-
TC/HA-70, and one to three “arms” of the HA-33/HA-17 trimer (two HA-33 and one HA-17) further bind to M-
TC/HA-70 via HA-17 and HA-70 binding, yielding one-, two-, and three-arm L-TC. Of all TCs, only the three-
arm L-TC caused hemagglutination. In this study, we determined the solution structures for the botulinum TCs
using small-angle X-ray scattering (SAXS). The mature three-arm L-TC exhibited the shape of a “bird spreading
its wings”, in contrast to the model having three “arms”, as revealed by transmission electron microscopy. SAXS
images indicated that one of the three arms of the HA-33/HA-17 trimer bound to both HA-70 and BoNT. Taken
together, these ﬁndings regarding the conformational changes in the building-block architecture of TC may
explain why only three-arm L-TC exhibited hemagglutination.
1. Introduction
Clostridium botulinum produces botulinum neurotoxin (BoNT), the
most potent toxin in nature. This neurotoxin is a causative agent of
human and animal botulism disease and can be classiﬁed into seven
serotypes (A–G) [1]. Serotypes A, B, E, and F are associated with
human botulism, whereas serotypes C and D predominantly cause
animal and avian disease. BoNT is a metalloendopeptidase having a
zinc ion in its molecule [2]. BoNT targets nerve endings at the
neuromuscular junction and enters into nerve cells via endocytosis,
after which BoNT cleaves the speciﬁc site in soluble NSF attachment
protein receptors (SNAREs) associated with neurotransmitter release
[3–5]. This process results in muscle paralysis and may cause death in
both humans and animals.
In culture ﬂuids and contaminated foods, BoNT is present as a part
of a toxin complex (TC) through its associations with auxiliary nontoxic
proteins, i.e., nontoxic nonhemagglutinin (NTNHA) and three types of
hemagglutinin (HA; HA-70, HA-33, and HA-17). BoNT is susceptible
to digestion in the gastrointestinal tract of humans and animals;
therefore, its toxicity is decreased when it is exposed to digestive
juices. However, when part of the TC, BoNT is stable, even in the
presence of digestive juices [6]. Thus, nontoxic proteins play a role in
protection of BoNT against digestive conditions. Furthermore, the HA
protein may facilitate transepithelial transport at the intestinal wall [7].
Recent studies have shown that the serotype A TC disrupts the E-
cadherin-mediated intercellular barrier of the intestinal epithelia and
facilitates the paracellular absorption of the TC [8].
In the TCs produced by serotype C and D strains, there are two
types of TCs: hemagglutination-negative and hemagglutination-posi-
tive TCs [9,10]. Hemagglutination-negative TCs are referred to as M-
TCs and include BoNT and NTNHA, whereas hemagglutination-
positive TCs are referred to as L-TCs and include M-TC and HA
proteins. Therefore, hemagglutination is thought to be caused by HA
proteins [9]. However, we have previously identiﬁed an intermediate
TC species [11]. M-TC is composed of a single molecule of BoNT and a
single molecule of NTNHA. The HA-70 trimer is attached to the M-TC
molecule via an interaction between NTNHA and HA-70, yielding the
M-TC/HA-70 complex. Additionally, three “arms” of the HA-33/HA-17
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trimer (a complex of two HA-33 proteins and one HA-17 protein) are
bound to the M-TC/HA-70, forming mature three-arm L-TC [12]. As
intermediates between the M-TC/HA-70 to three-arm L-TC, one- and
two-arm L-TCs, which have only one or two “arms” of the HA-33/HA-
17 trimer, respectively (see Fig. 1), have also been observed. The
botulinum TC is not formed by random association of the component
proteins, but is constructed through a speciﬁc mechanism; thus the
construction of botulinum TC is a sort of “building-block architecture”.
Interestingly, hemagglutination occurs only by the three-arm L-TC, but
not by intermediate TC species, although these species also contain HA
proteins [11].
In this study, we aimed to determine the solution structure of the
“building-block” TC species, including the M-TC, M-TC/HA-70, one-
arm L-TC, two-arm L-TC, and three-arm L-TC. Furthermore, we
discussed the relationship between the molecular conformation of the
TC species and hemagglutination.
2. Materials and methods
2.1. Production and puriﬁcation of TC species
C. botulinum serotype D strain 4947 was cultured anaerobically for
5 days using dialysis [13]. Crude TC was precipitated with 60% (w/v)
saturated ammonium sulfate, dialyzed against 50 mM acetate buﬀer
N
at
iv
e-
PA
G
E
M-TC
(kDa)
(kDa)
M-TC/HA-70 One-arm L-TC Two-arm L-TC Three-arm L-TC
M-TC
“Building Block” Model
for botulinum TC formation
M-TC/HA-70 One-arm L-TC Two-arm L-TC Three-arm L-TC
97
66
45
30
20.1
14.4
SD
S-
PA
G
E
HA-33
HA-17
HA-33 HA-33
HA-70 HA-70
HA-17 HA-17
HA-70 HA-70
BoNT
NTNHA
BoNT
NTNHA
BoNT
NTNHA
BoNT
NTNHA
BoNT
BoNT
NTNHA
HA-33
HA-17
HA-70
NTNHA
669
440
232
140
R
el
at
iv
e 
am
ou
nt
 
of
 c
om
po
ne
nt
Fig. 1. Building-block architecture model for the botulinum toxin complex (TC). All TC species were developed on the SDS-PAGE and native PAGE as shown in supplementary ﬁg. 1.
Relative amounts of each component in the TC species are represented by the width of the ribbon. As shown in the “building-block”model in the bottom of the ﬁgure, the M-TC matured
into the three-arm L-TC via intermediate TC species, including M-TC/HA-70, one-arm L-TC, and two-arm L-TC.
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(pH 4.0) containing 0.2 M NaCl, and applied to a TOYOPEARL SP-
650S (Tosoh, Tokyo, Japan) cation-exchange column (1.6 cm×40 cm)
equilibrated with dialysis buﬀer. TC species bound to the resin were
eluted with a linear gradient of NaCl (0.2–0.8 M). Each fraction (M-TC,
M-TC/HA-70, one-arm L-TC, two-arm L-TC, and three-arm L-TC) was
pooled separately, concentrated, and further puriﬁed with a HiLoad
16/60 Superdex 200 pg gel-ﬁltration column (GE Healthcare, Little
Chalfont, UK 1.6 cm×60 cm) equilibrated with 50 mM acetate buﬀer
(pH 5.0) containing 0.15 M NaCl. The TC fraction was then applied to a
Mono S HR5/5 cation-exchange column (GE Healthcare UK;
0.5 cm×5 cm) equilibrated with 50 mM acetate buﬀer (pH 5.0) and
eluted using a linear gradient of NaCl (0–0.5 M). The purities of the M-
TC, M-TC/HA-70, one-arm L-TC, two-arm L-TC, and three-arm L-TC
were evaluated by native PAGE and SDS-PAGE.
2.2. PAGE
PAGE under nondenaturing conditions (native PAGE) was carried
out at pH 8.8 using 5–12.5% polyacrylamide linear gradient gels. SDS-
PAGE was performed as described by Laemmli [14] using 13.6%
polyacrylamide gels in the presence of 2-mercaptoethanol. The sepa-
rated protein bands were detected with Coomassie Brilliant Blue R-
250.
2.3. Small-angle X-ray scattering analysis (SAXS)
SAXS measurements of the botulinum TC species puriﬁed from
strain D 4947 (5 mg/mL) in 10–20 µL of 50 mM acetate buﬀer (pH
4.0) were performed on a Rigaku BioSAXS-1000 (Rigaku, Tokyo,
Japan). In total, eight datasets were collected after 120 min of exposure
(15 min per data set). Raw data were analyzed using the SAXSLab
software package (Rigaku). SAXS curves were generated after subtract-
ing solvent scattering using the program PRIMUS from the ATSAS
package.
2.4. Measurement of the association constant using a quartz crystal
microbalance
To measure the association constant (Ka) between the HA-33/HA-
17 trimer and TC species, including the M-TC/HA-70, one-arm L-TC,
and two-arm L-TC, 27-MHz quartz crystal microbalance (QCM)
analysis using AﬃnixQ4 (Initium, Chigasaki, Japan) was performed.
After rinsing with 1% SDS and Piranha solution, the electrode was
exposed to 100 µL of 3,3′-dithiodipropionic acid (210 µg/mL) for
60 min and exposed to 100 µL of a 1:1 mixture of N-hydroxysuccini-
mide (NHS; 20 mg/mL) and 1-ethyl-3-(3-dimethylaminopropyl) car-
bodiimide, hydrochloride (20 mg/mL) for 15 min. The electrode was
covered with 450 µL of TC species (100 µg/mL) in 10 mM phosphate
buﬀer (pH 6.0) containing 0.15 M NaCl and incubated for 30 min.
Thereafter, the electrode was covered with 100 µL of 1 M 2-aminoetha-
nol (pH 8.5) and incubated for 30 min to deactivate the free NHS
residues on the electrode. Measurement of the frequency change was
performed in the presence of various concentrations (10–200 nM) of
HA-33/HA-17 trimer in 10 mM phosphate buﬀer (pH 6.0) containing
0.15 M NaCl and blocking reagent for AﬃnixQ (Initium). The Ka values
were calculated using AQUA software (Initium).
3. Results and discussion
In this study, we isolated and puriﬁed several TC species, including
the M-TC, M-TC/HA-70, one-arm L-TC, two-arm L-TC, and three-arm
L-TC, from the culture supernatants of the C. botulinum serotype D
4947. Components of the puriﬁed TC species were developed on
denaturing SDS-PAGE, as shown in Fig. 1 (original gel picture is
shown in supplementary ﬁgure 1). The M-TC and M-TC/HA-70 were
composed of BoNT/NTNHA and BoNT/NTNHA/HA-70, respectively.
In contrast, the one- to three-arm L-TCs were complexes of BoNT/
NTNHA/HA-70/HA-17/HA-33. Staining intensities for the protein
bands representing BoNT, NTNHA, and HA-70 were similar for all
TC species. However, the intensities of the protein bands representing
Fig. 2. Solution structures of the botulinum TC species revealed by SAXS analyses. The upper row of images shows SAXS images of each TC species with crystal structures for a single
molecule of serotype A M-TC, a single molecule of serotype C HA-70 trimer, and one to three molecules of serotype D HA-33/HA-17 trimers, which were manually superimposed on the
SAXS image such that all molecules were ﬁtted into the image (see Supplementary Movie 1). The second row indicates the model of each molecule represented as cartoon images of the
crystal structures. The lowest row indicates the scheme of each molecule with the assembly pathway of the HA proteins to the M-TC molecule.
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HA-33 and HA-17 were increased as the number of “arms” increased
for L-TCs.
Each of the puriﬁed TC species was subjected to SAXS analysis, and
the dummy atom model (DAM) was generated as shown in Fig. 2. The
maximum diameters of the M-TC, M-TC/HA-70, one-arm L-TC, two-
arm L-TC, and three-arm L-TC were found to be 150, 177, 234, 277,
and 400 Å, respectively. Previously, Hasegawa et al. [12] demonstrated
that mature L-TC from serotype D displayed an ellipsoidal-shaped
structure with three “arms” attached, based on transmission electron
microscopy (TEM) images. Similar structures were also identiﬁed in
serotypes A and B botulinum TCs [15], based on a combination of TEM
and crystallographic analyses. Hasegawa et al. [12] also showed that
the one or two “arms” are attached structures for the one-arm and two-
arm L-TCs, respectively. However, the SAXS image displayed only one
“arm”-like structure for both the one-arm L-TC and two-arm L-TC. In
the SAXS image for the three-arm L-TC, only two “arms” were
extended, and the appearance of the three-arm L-TC exhibited a shape
resembling a “bird spreading its wings”. As shown in Fig. 2, we
constructed a model of the coordination of each component in the
TC species based on the superimposition of the SAXS image and
representation of the crystal structure. In this model, the discrepancy
between the SAXS image showing only two “wings” and the TEM
images showing three “arms” could be explained by coordination of the
“second arm”, which was composed of a HA-33/HA-17 trimer attached
during formation of the two-arm L-TC. The HA-33/HA-17 trimer could
interact with the M-TC/HA-70 via binding with HA-17/HA-70 and
HA-33/BoNT. Therefore, the ﬁrst and third “arms” of the HA-33/HA-
17 trimer could explain the appearance of “spreading wings” in the
SAXS “bird” model.
Supplementary material related to this article can be found online
at http://dx.doi.org/10.1016/j.bbrep.2016.11.008.
Previously, Beneﬁeld et al. [16] suggested that the “arms” of the
HA-33/HA-17 trimer in the 16S PC (corresponding to our three-arm L-
TC) are ﬂexible, and the trimer in 90% of the TC displayed a “ﬂat”
orientation containing an ovoid body with only two well-deﬁned arms.
Thus, these data suggest that one of the three “arms” of the HA-33/HA-
17 trimer is attached to the ovoid body. Sharma and Singh [17]
reported that the HA-33 molecule interacts with BoNT via strong
protein-protein interactions. These reports also supported the addi-
tional interaction between HA-33 and BoNT molecules in the TC. To
detect the unique interaction in the second “arm” of the HA-33/HA-17
trimer with the one-arm L-TC, the binding kinetics of the HA-33/HA-
17 trimer to the M-TC/HA-70, one-arm L-TC, and two-arm L-TC were
analyzed using a QCM-based method. As shown in Table 1, the Ka
values for binding of the HA-33/HA-17 trimer with the M-TC/HA-70,
one-arm L-TC, and two-arm L-TC were found to be 0.004, 0.16, and
0.016, respectively. Thus, binding of the HA-33/HA-17 trimer with the
one-arm L-TC was the strongest interaction among the combinations
tested.
As shown in Fig. 3, our model for the solution structure of
botulinum TC species would explain why only the three-arm L-TC
exhibited hemagglutination. The membrane of the erythrocyte is
negatively charged due to the sialic acid on the sugar chain attached
to the cell surface. If the erythrocytes are suspended in an ionic
medium, such as saline, which is usually employed in hemagglutination
assays, cations arrange themselves around each cell to form an ionic
cloud. The ionic cloud keeps erythrocytes from adhering to each other
in the peripheral blood. Thus, the potential providing the force that
repels erythrocytes from each other, which is created by the ionic cloud,
is the zeta potential [18]. In solution, the zeta potential kept the
erythrocytes about 250 Å apart (Fig. 3A). Therefore, to exhibit hemag-
glutination, a protein must have at least two cell surface binding sites,
and the distance between the two sites must be greater than 250 Å. As
shown in Fig. 3B, the M-TC/HA-70, one-arm L-TC, and two-arm L-TC
possessed multiple cell binding sites. However, the distances between
the binding sites were estimated to be approximately 130, 160, and
200 Å, respectively, based on the arrangements of the components in
Table 1
Association constants (Ka) for the binding between HA-33/HA-17 and TC species based
on the QCM analysis.
Guest: Host Ka (nM
−1)
HA-33/HA-17: M-TC/HA-70 0.004
HA-33/HA-17: 1-arm L-TC 0.16
HA-33/HA-17: 2-arm L-TC 0.016
250Å
M-TC/HA-70
Zeta potential
Zeta potential
erythrocyte
250Å
A B
One-arm
 L-TC
Two-arm
 L-TC
Three-arm
 L-TC
Estimated distance 
between cell-binding sites ~130 Å ~160 Å ~200 Å ~350 Å
erythrocyte
Bind to Only One Cell
Do not aggregate
Bind to Two Cells
Aggregate
Fig. 3. Schematic diagram of erythrocytes in the ionic solution and the botulinum TC species binding to the surface of the cells. A. In the ionic solution, erythrocytes were positioned
approximately 250 Å apart due to the zeta potential created by the cationic cloud surrounding the negatively charged erythrocytes, resulting from the presence of sialic acid on the cell
surface. B. Schematic indicating the size of the gap between two erythrocytes and the botulinum TC species. Magenta closed-circles indicate the cell-binding sites on the HA-33 and HA-
70 molecules suggested by Sugawara et al. [21]. In all TC species except for the three-arm L-TC, TC could bind to a single erythrocyte, but could not bind to two cells because of the
proximity of the two cell-binding sites. Thus, the erythrocytes did not aggregate. In contrast, the three-arm L-TC could bind concomitantly to two cells because two cell-binding sites on
the HA-33 protein could allow a suﬃcient distance to be maintained between the two cells.
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the TC and the Dmax of each TC. In contrast, in the three-arm L-TC,
the distance between the cell-binding sites in two HA-33 molecules in
the “two wings” was estimated as ~350 Å and was therefore longer than
250 Å. Thus, only the three-arm L-TC exhibited hemagglutination. The
maximum diameter of the three-arm L-TC was determined to be 400 Å
using SAXS analysis. The arrangement of components in the SAXS
image indicated that this diameter represented the width of the HA
complex (HA-70/HA-17/HA-33 complex). However, the width of the
serotype-A HA complex was determined to be approximately 260 Å,
based on the TEM analysis [15]. The discrepancy in the size of the
complex may be explained by the structural ﬂexibility of the HA
proteins, as shown in previous reports describing SAXS analyses
[19,20].
In summary, these ﬁndings suggested that the HA complex plays an
important role in the transepithelial transport of the toxin, which may
be associated with the ﬂexibility of the complex. The assembly pathway
of the TC also would be dynamic. Although the structure of the
botulinum TC has been gradually elucidated, current information is
limited to the static structure. Thus, dynamic analyses including SAXS-
based methods will help to clarify the pathogenic mechanisms of the
botulinum TC.
Transparency document. Supplementary document
Transparency document associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.bbrep.2016.11.008.
Appendix A. Transparency document
Supplementary data associated with this article can be found in the
online version at http://dx.doi.org/10.1016/j.bbrep.2016.11.008.
References
[1] K.K. Hills, T.J. Smith, C.H. Helma, L.O. Ticknor, B.T. Foley, R.T. Svensson,
J.L. Brown, E.A. Johnson, L.A. Smith, R.T. Okinaka, P.J. Jackson, J.D. Marks,
Genetic diversity among botulinum neurotoxin-producing clostridial strains, J.
Bacteriol. 289 (2007) 818–832.
[2] G. Schiavo, O. Rossetto, A. Santucci, B.R. DasGupta, C. Montecucco, Botulinum
neurotoxins are zinc proteins, J. Biol. Chem. 287 (1992) 23479–23483.
[3] C. Montecucco, G. Schiavo, Mechanism of action of tetanus and botulinum
neurotoxins, Mol. Microbiol. 13 (1994) 1–8.
[4] G. Schiavo, C.C. Shone, M.K. Bennett, R.H. Scheller, C. Monteccuco, Botulinum
neurotoxin type C cleaves a single Lys-Ala bond within the carboxyl-terminal region
of syntaxins, J. Biol. Chem. 270 (1995) 10566–10570.
[5] O. Rossetto, M. Pirazzini, C. Montecucco, Botulinum neurotoxins: genetic, struc-
tural and mechanistic insights, Nat. Rev. Microbiol. 12 (2014) 535–549.
[6] K. Miyata, T. Yoneyama, T. Suzuki, H. Kouguchi, K. Inui, K. Niwa, T. Watanabe,
T. Ohyama, Expression and stability of the nontoxic component of the botulinum
toxin complex, Biochem. Biophys. Res. Commun. 384 (2009) 126–130.
[7] H. Ito, Y. Sagane, K. Miyata, K. Inui, T. Matsuo, R. Horiuchi, T. Ikeda, T. Suzuki,
K. Hasegawa, H. Kouguchi, K. Oguma, K. Niwa, T. Ohyama, T. Watanabe, HA-33
facilitates transport of the serotype D botulinum toxin across a rat intestinal
epithelial cell monolayer, FEMS Immnunol. Med. Microbiol. 61 (2011) 323–331.
[8] K. Lee, X. Zhong, S. Gu, A.M. Kruel, M.B. Dorner, K. Perrry, A. Rummel, M. Dong,
R. Jin, Molecular basis for disruption of E-cadherin adhesion by botulinum
neurotoxin A complex, Science 334 (2014) 1405–1410.
[9] K. Oguma, Y. Fujinaga, K. Inoue, Structure and function of Clostridium botulinum
toxins, Microbiol. Immunol. 39 (1995) 161–168.
[10] T. Ohyama, T. Watanabe, Y. Fujinaga, K. Inoue, H. Sunagawa, N. Fujii, K. Inoue,
K. Oguma, Characterization of nontoxic-nonhemagglutinin component of the two
types of progenitor toxin (M and L) produced by Clostridium botulinum type D CB-
16, Microbiol. Immunol. 39 (1995) 457–465.
[11] S. Mutoh, H. Kouguchi, Y. Sagane, T. Suzuki, K. Hasegawa, T. Watanabe,
T. Ohyama, Complete subunit structure of the Clostridium botulinum type D toxin
complex via intermediate assembly with nontoxic components, Biochemistry 42
(2003) 10991–10997.
[12] K. Hasegawa, T. Watanabe, T. Suzuki, A. Yamano, T. Oikawa, Y. Sato, H. Kouguchi,
T. Yoneyama, K. Niwa, T. Ikeda, T. Ohyama, A novel subunit structure of
Clostridium botulinum serotype D toxin complex with three extended arms, J. Biol.
Chem. 282 (2007) 24777–24783.
[13] K. Hasegawa, T. Watanabe, H. Sato, Y. Sagane, S. Mutoh, T. Suzuki, A. Yamano,
H. Kouguchi, K. Takeshi, A. Kamaguchi, Y. Fujinaga, K. Oguma, T. Ohyama,
Characterization of toxin complex produced by a unique strain of Clostridium
botulinum serotype D 4947, Protein J. 23 (2004) 371–378.
[14] U.K. Laemmli, Cleavage of structural proteins during the assembly of the head of
bacteriophage T4, Nature 227 (1970) 680–685.
[15] K. Lee, S. Gu, L. Jin, T.T.N. Le, L.W. Cheng, J. Strotmeier, A.M. Kruel, G. Yao,
K. Perry, A. Rummel, R. Jin, Structure of a bimodular botulinum neurotoxin
complex provides insights into its oral toxicity, PLoS Pathog. 9 (2013) e1003690.
[16] D.A. Beneﬁeld, S.K. Dessain, N. Shine, M.D. Ohi, D.B. Lacy, Molecular assembly of
botulinum neurotoxin progenitor complexes, Proc. Natl. Acad. Sci. USA 110 (2013)
5630–5635.
[17] S.K. Sharma, B.R. Singh, Enhancement of the endopeptidase activity of puriﬁed
botulinum neurotoxins A and E by isolated component of the native neurotoxin
associated proteins, Biochemistry 43 (2004) 4791–4798.
[18] R.A. McPherson, M.R. Pincus, Herry's Clinical Diagnosis and Management by
Laboratory Methods, twenty-second, Elsevier, Amsterdam, 2011.
[19] Y. Sagane, S. Hayashi, T. Matsumoto, S.-,I. Miyashita, K. Inui, K. Miyata, S. Yajima,
T. Suzuki, K. Hasegawa, A. Yamano, A. Nishikawa, T. Ohyama, T. Watanabe,
K. Niwa, Sugar-induced conformational change found in the HA-33/HA-17 trimer
on the botulinum toxin complex, Biochem. Biophys. Res. Commun. 438 (2013)
483–487.
[20] Y. Sagane, S. Hayashi, T. Akiyama, T. Matsumoto, K. Hasegawa, A. Yamano,
T. Suzuki, K. Niwa, T. Watanabe, S. Yajima, Conformational divergence in the HA-
33/HA-17 trimer of serotype C and D botulinum toxin complex, Biochem. Biophys.
Res. Commun. 476 (2016) 280–285.
[21] Y. Sugawara, M. Yutani, S. Amatsu, T. Matsumura, Y. Fujinaga, Functional
dissection of the Clostridium botulinum type B hemagglutinin complex: identiﬁ-
cation of the carbohydrate and E-cadherin binding sites, PLoS One 9 (2014)
e111170.
T. Suzuki et al. Biochemistry and Biophysics Reports 9 (2017) 67–71
71
